Protagonist Therapeutics Balance Sheet (2017-2025) | PTGX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Accumulated Depreciation (Quarter)				4.26M	4.53M	4.74M	4.97M	5.25M	5.49M	5.72M	5.95M	6.23M	6.47M	6.70M	6.93M	7.04M	7.27M	7.58M	7.94M	8.31M
Assets
Current Assets
Cash & Equivalents (Quarter)	83.00M	192.41M	120.54M	123.67M	98.48M	120.24M	152.82M	125.74M	127.69M	235.38M	230.53M	186.73M	172.57M	355.64M	131.12M	97.25M	139.65M	168.54M	113.71M	128.39M
Receivables - Net (Quarter)	0.10M
Receivables - Other (Quarter)	4.00M	7.08M	2.64M	1.57M	25.15M	0.04M	0.49M	0.04M	0.05M	0.04M		0.26M				165.00M	22.82M	4.52M	4.55M	4.37M
Receivables (Quarter)	4.10M	7.08M	2.64M	1.57M
Work In Process (Quarter)				1.57M			0.12M	0.01M				10.00M	300.04M	0.04M		165.00M
Prepaid Assets (Quarter)	6.21M	7.68M	8.88M	1.75M	1.43M	9.72M	9.05M	1.42M	1.49M	0.83M	0.07M	1.04M	1.33M	6.88M	0.22M	0.65M	0.81M	0.88M	0.74M	10.09M
Current Assets (Quarter)	285.51M	371.82M	327.69M	340.74M	341.52M	304.30M	276.62M	243.08M	235.74M	316.94M	324.88M	355.58M	627.55M	570.92M	476.77M	591.64M	605.86M	602.53M	586.42M	577.57M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.43M	1.72M	1.72M	0.26M	2.06M	1.96M	1.78M	0.16M	1.34M	1.26M	1.42M	0.06M	1.11M	1.78M	2.47M	3.19M	3.53M	4.11M	4.10M	3.86M
Long-Term Investments (Quarter)	6.30M	26.10M	38.20M								2.00M			31.40M	114.60M	140.25M	123.50M	102.50M	102.70M	78.64M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.23M	0.29M	0.29M	0.29M
Non-Current Assets (Quarter)	12.56M	32.41M	45.49M	6.96M	6.77M	6.21M	5.56M	4.63M	4.12M	3.52M	5.13M	2.15M	1.72M	43.70M	127.09M	12.61M	136.27M	115.48M	115.26M	11.69M
Assets (Quarter)	298.07M	404.23M	373.18M	347.69M	348.30M	310.51M	282.17M	247.93M	239.86M	320.47M	330.02M	357.95M	629.28M	614.63M	603.86M	744.73M	742.13M	718.01M	701.69M	668.19M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	17.68M	7.91M	0.71M	37.72M	32.87M	1.41M	4.71M	24.95M	4.02M	19.37M	1.25M	0.77M	16.49M	15.18M	20.74M	1.61M	11.84M	3.25M	22.87M	28.27M
Payables (Quarter)	17.68M	7.91M	0.71M	37.72M	32.87M	1.41M	4.71M	24.95M	4.02M	19.37M	1.25M	0.77M	16.49M	15.18M	20.74M	1.61M	11.84M	3.25M	22.87M	28.27M
Short term Debt (Quarter)	6.82M	11.40M	1.12M	0.90M	0.38M	0.08M	0.03M	0.07M	0.02M	0.01M
Current Leases (Quarter)	1.51M	1.57M	2.03M	2.20M	2.27M	2.35M	2.43M	2.52M	2.60M	2.45M	1.80M	1.14M	0.46M		0.04M	0.51M	1.57M	2.17M	2.23M	2.28M
Current Taxes (Quarter)													3.33M	2.65M	1.05M	2.69M	1.89M
Current Deferred Revenue (Quarter)	5.77M	2.01M	2.24M	1.60M	0.77M		0.03M	0.07M			0.00M	0.00M	16.12M	40.90M	19.70M	18.89M	16.89M	14.69M	14.20M	9.55M
Total Current Liabilities (Quarter)	34.52M	42.97M	39.16M	44.02M	43.46M	40.09M	36.75M	31.18M	23.23M	26.40M	27.87M	21.27M	39.91M	41.58M	44.58M	47.40M	35.11M	35.51M	44.94M	45.44M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)													28.92M	20.76M	16.51M	11.68M	8.18M	5.38M	2.79M
Operating Leases (Quarter)	4.10M	3.69M	4.24M	3.66M	3.06M	2.45M	1.80M	1.14M	0.46M					10.97M	10.86M	10.36M	9.79M	9.11M	8.52M	8.04M
Other Non-Current Liabilities (Quarter)	0.12M	0.12M	0.12M
Total Non-Current Liabilities (Quarter)	38.62M	46.66M	43.39M
Total Liabilities (Quarter)	38.74M	46.78M	43.52M	47.67M	46.52M	42.53M	38.56M	32.32M	23.69M	26.40M	27.87M	21.27M	68.83M	73.31M	71.94M	69.43M	53.08M	49.99M	56.25M	53.48M
Shareholder's Equity
Total Debt (Quarter)	6.82M	11.40M	1.12M	0.90M	0.38M	0.08M	0.03M	0.07M	0.02M	0.01M
Common Equity (Quarter)	259.33M	357.45M	329.66M	300.02M	301.78M	267.98M	243.62M	215.61M	216.17M	294.07M	302.15M	336.68M	560.44M	541.32M	531.91M	675.29M	689.05M	668.02M	645.44M	614.71M
Shareholder's Equity (Quarter)	259.33M	357.45M	329.66M	300.02M	301.78M	267.98M	243.62M	215.61M	216.17M	294.07M	302.15M	336.68M	560.44M	541.32M	531.91M	675.29M	689.05M	668.02M	645.44M	614.71M
Liabilities and Shareholders Equity (Quarter)	298.07M	404.23M	373.18M	347.69M	348.30M	310.51M	282.17M	247.93M	239.86M	320.47M	330.02M	357.95M	629.28M	614.63M	603.86M	744.73M	742.13M	718.01M	701.69M	668.19M
Retained Earnings (Quarter)	-0.03M	-338.70M	-372.50M	-0.30M	-430.30M	-471.33M	-0.48M	-536.75M	-570.50M	-608.90M	-0.17M	-0.10M	-408.40M	-0.25M	-472.20M	-0.08M	-352.18M	-386.90M	-426.30M	0.64M
Treasury Shares (Quarter)					0.61M	0.77M	0.69M		0.20M	0.09M		0.08M				0.84M				1.29M
Shares Outstanding (Quarter)					48.55M	48.68M	49.20M		51.44M	57.49M	57.65M	57.71M	58.60M	58.76M	59.52M	61.04M	61.93M	62.11M	62.45M	62.58M

Research Tools

Protagonist Therapeutics Balance Sheet (2017-2025) | PTGX

Create an account

Sign In

Reset Password